Tiotropium containing powder formulation for inhalation

Apply for Patent – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Boehringer Ingelheim Pharma Gmbh & Co. Kg patent solves the following problem:

Tiotropium bromide is known from European Patent Application EP 418 716 A1 and the following chemical structure:

Our analysis of this patent is as follows:

Boehringer Ingelheim Pharma Gmbh & Co. Kg’s patent US 7763280 B2 deals with Tiotropium containing powder formulation for inhalation.
The invention relates to powdered preparations containing tiotropium for inhalation, processes for preparing them as well as their use in preparing a pharmaceutical composition for the treatment of respiratory complaints, especially for treatment COPD (chronic obstructive pulmonary disease) and asthma.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Mobile terminal apparatus and software install method

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The Fujitsu Limited patent solves the following problem:

The present invention relates to a technology for installing software on a mobile terminal equipment of a peripheral device to be connected.

Our analysis of this patent is as follows:

Fujitsu Limited’s patent US 7761883 B2 deals with Mobile terminal apparatus and software install method.
A unit-source monitoring software monitors a software source that provides software needed for use with peripheral devices, and store data about acquirable software and software source in a corresponding manner to a unit memory. A unit of peripheral-device monitoring monitor connection status of peripheral devices. A software-source selecting unit selects the software source based on data stored in the memory unit when the unit peripheral-device monitoring detects the connection of peripheral devices. An installation discharge unit acquires software from source software chosen by the selection unit-source software.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Nucleic acid and protein homologs and uses thereof

File for Quick & Easy Patent Protection with PowerPatent.

The Abt Holding Company patent solves the following problem:

Gene is the basic unit of information that is inherited in an organism and so many mechanisms available to ensure the stability of their ranks over many generations. These strengthen mechanisms to ensure that the order of the nucleotides that contain a gene to stay in a constant form during, and since this nucleotide sequences encoding the regulatory sequence is to determine gene expression and coding sequences that determine protein structure and function of these genetic properties also stably maintained. following the race that the gene can be distinguished based on differences in their ranks. The gene sequences to determine the expression pattern and function of the gene and the protein product, thus gene with a different order are expected to display different biological functions. The protein translated from this array of genes to serve as the foundation for building more complex structures and catalytic machinery that is the basis for metabolic, developmental and physiological processes complex organisms and life possible. The final location of these structures and their corresponding functional activity also determined the underlying gene sequences that code for their formation. New assessments of the human genome is estimated that the human genome contains approximately 140,000 genes. Although each of these sequences varied role, many of these genes can be grouped into classes based on the function of the proteins for which they encode. Instead, when a gene sequence is translated into a protein that appears to be linked to an important physiological way, it may be particularly relevant for diagnostic and therapeutic use. The recognition and functional characteristics of all of the genetic determinants of life are among the challenges in modern biology and medicine.

Our analysis of this patent is as follows:

Abt Holding Company’s patent US 7420044 B1 deals with Nucleic acid and protein homologs and uses thereof.
The present invention relates to the identification of novel nucleic acid molecules and the proteins encoded by these nucleic acid molecules, as well as their production for use as therapeutics, diagnostics and for research purposes.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Microtubule-associated proteins and tubulins

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Incyte Corporation patent solves the following problem:

The cytoskeleton, a cytoplasmic protein fiber system, mediated cell form, structure, and movement. cytoskeleton supports the cell membrane and forms tracks organelles and other elements move in the cytosol. cytoskeleton is a dynamic structure that allows the cells to adopt different forms and in obeying the action. Major cytoskeletal fibers are microfilaments, microtubules, and intermediate filaments. Motor proteins including myosin, dynein and kinesin, drive or movement along the fibers. Accessories or associated protein modification or structural strength of the fibers while cytoskeletal membrane anchors connect the fibers to the cell membrane.

Our analysis of this patent is as follows:

Incyte Corporation’s patent US 6962799 B2 deals with Microtubule-associated proteins and tubulins.
the invention provides human microtubule-associated protein and tubulins (MICAPTUB) and polynucleotides which identify and encode MICAPTUB. invention also provides expression vector, host cells, antibodies, agonists and antagonists. invention also provides methods for diagnosing, treating, or preventing diseases associated with aberrant expression of MICAPTUB.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Human hydrolytic enzymes

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Incyte Corporation patent solves the following problem:

Hydrolysis is the breaking of a covalent bond to a substrate by the introduction of a water molecule. The reaction involves a nucleophilic attack of oxygen atoms in water molecules in a target substrate bond. The water molecules split across the target bond, breaking the bond and produce two molecules. Hydrolytic enzyme involved in the reactions of important functions such as cell signaling, cell proliferation, inflammation, apoptosis, secretion and excretion. Hydrolytic enzyme involved in the key steps in the disease process involving these functions. Hydrolytic enzyme, or hydrolases, a group of substrate specificity of classes including aminohydrolases, phospholipases, carboxyl-esterases, phosphodiesterases, lysozymes, glycosidases, glyoxalases, sulfatases, phosphohydrolases, and serine hydrolases.

Our analysis of this patent is as follows:

Incyte Corporation’s patent US 6872560 B1 deals with Human hydrolytic enzymes.
human invention provides hydrolytic enzymes (HYENZ) and polynucleotides which identify and encode HYENZ. the invention also provide expression vector, host cells, antibodies, agonists and antagonists. invention also provides methods for diagnosing, treating, or preventing diseases associated with expression of HYENZ.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Intrabuccally dissolving compressed moldings and production process thereof

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Yamanouchi Pharmaceutical Co., Ltd patent solves the following problem:

Dosage forms easier teaching the patient was brought to the attention of the scarce despite the existence of various known dosage forms of medicinal preparations for oral administration use. So, the great concern is directed to the development of a dosage form that is easy to use, particularly in elderly or children who have difficulty swallowing oral preparations.

Our analysis of this patent is as follows:

Yamanouchi Pharmaceutical Co., Ltd’s patent US 5576014 A deals with Intrabuccally dissolving compressed moldings and production process thereof.
Intrabuccally gradually compressed moldings comprising a saccharide of low moldability granulated with a saccharide having high moldability. The laces of the present invention showed quick disintegration and dissolution in the buccal cavity and have a sufficient hardness.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Patient identification system

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The Shamos; Morris H. patent solves the following problem:

The present invention relates to the field of patient identification, especially the methods, devices and systems to strengthen the identity of a person to receive a treatment with the patients for whom the treatment is intended.

Our analysis of this patent is as follows:

Shamos; Morris H.’s patent US 5381487 A deals with Patient identification system.
States is a way to strengthen the identity of a patient in a man receiving a treatment for said patients, by (a) obtaining a print indentification nature of said patient; (B) to obtain a print identification characteristic of said individual to whom the treatment is intended to be administered; (C) has confirmed the birth to print identification characteristics obtained from patients with print identification characteristics derived from the individual. Also disclosed that a fighting devices and systems. The device information will identify one or more than one patient.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Updatable micrographic pocket data card

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Drexler Technology Corporation patent solves the following problem:

Our analysis of this patent is as follows:

Drexler Technology Corporation’s patent US 4814594 A deals with Updatable micrographic pocket data card.
A strip of Optical contrast laser recording material would wallet-size card, and laser written characters recorded thereon. The characters are formed with a plurality of pixels, similar in nature to the dots that make up character dot matrix, except that the pixels themselves formed spots. The spots thrown in a geometric regular war and often written in a column at a time until a full pixel formed. Machine readable and visually readable characters can be combined in a strip of data.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Method of forming a personal information card

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Drexler Technology Corporation patent solves the following problem:

Identification cards used in magnetic data strips with photographic prints of the card owner. US Pat. No. 4,360,728, Drexler said a bank card for automatic teller machines bearing a strip of magnetic recording material, and a direct-read-after-write reflective laser recording material.

Our analysis of this patent is as follows:

Drexler Technology Corporation’s patent US 4692394 A deals with Method of forming a personal information card.
Personal information is recorded in a medium of information containing the two visual images, such as a face or fingerprint, and laser recorded data. The visual images created on a piece of photographic material or eyes read laser recording material. The visual image material followed by a face of a wallet-sized card. A strip of laser recordable optical data storage material also followed the card. After the strip is placed on the card, a laser recording personal information indicia strip in situ. strip may be a reflective silver material particles in a gelatin matrix; recording spots with a noticeable difference in reflectivity. card can be coated with a transparent protective laminate material.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Medical data card having internal illumination

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Data Medi-Card, Inc. patent solves the following problem:

This creation relates generally to a medical data card containing a summary of the medical history will be involved in his current medical condition, and especially an internal illuminated card in this manner that the front and rear transparencies component in a relatively large data capacity, the data taken as read and read directly without the need for optical lens.

Our analysis of this patent is as follows:

Data Medi-Card, Inc.’s patent US 4575127 A deals with Medical data card having internal illumination.
An internal illuminated medical data card in a credit card format containing a summary of the medical history will be involved in his current medical condition. The card, which is laminated construction, includes a core panel formed in front and rear plastic section with light-passing possession, a metallized layer functioning as a double-who facing glass sandwiched therebetween. Depend on the respective faces of the core is the section in front of and behind the film transparencies containing medical data in a direct read scale, the combined data elements in the daily summary. The long side and one end of each core section is a concave formation to define reflective convex end where the light to enter the remaining flat end section passed so the convex end glass and by giving many internal reflection, causing the light to shine on transparencies to improve their readability.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.